6d
GlobalData on MSNOCT West Coast 2025: China surpasses US for annual number of clinical trialsGlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
The U.S. always seems to be in competition with China—economically, technologically, militarily. But how do the two countries stack up when it comes to measuring the health of its people? Going by ...
But if current trends hold, by 2044, China will inch past the U.S.'s 82. ... connected to long-known risks ranging from tooth decay to obesity. The U.S. is the second-highest consumer of ...
Read about the top 15 political, economic, social, environmental, technology and industry trends that will shape 2025 and beyond ...
Following a second day of stock market gains, investors looked forward to earnings reports from Eli Lilly and Amazon.
MR: We’ve been looking at a lot of opportunities, particularly in China, where they’re like the same drug over and over again. We are staying away from those. No ‘me toos’ in obesity ...
The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results